Skip to content
Menu
Wicked Sister
Wicked Sister

Category: Multiple Sclerosis Research

Water exercise beats standard PT for MS fatigue, balance issues

Posted on December 2, 2025 by

Aquatic therapy significantly eased fatigue and improved balance in multiple sclerosis (MS) patients in a clinical trial in Greece, outperforming results from a control group who participated in a conventional physiotherapy program. “Our work suggests that incorporating [aquatic therapy] into MS care can meaningfully alleviate fatigue and balance deficits, thereby improving patients’ functional capabilities and…

+

Welcome December

Posted on December 2, 2025 by

I am a day late with saying this, but happy December to y’all! Can you believe it is already December? Where has the year gone? It seems the older I get, the faster the years fly by. At this moment, which I know can change at any time, the weather has finally been colder. Mother…

+

Multiple sclerosis economic burden exceeds $3 billion as prevalence soars in Australia

Posted on December 2, 2025 by

The post Multiple sclerosis economic burden exceeds $3 billion as prevalence soars in Australia appeared first on MS Australia. Source: www.msaustralia.org.au

+

Oral bacteria tied to more severe multiple sclerosis symptoms

Posted on December 2, 2025 by

People with multiple sclerosis (MS) who have higher levels of Fusobacterium nucleatum in the mouth — bacteria that can contribute to periodontitis, a serious gum infection — may be more likely to experience more severe symptoms, according to a study from Japan. This finding adds to recent preclinical evidence suggesting that periodontitis may be associated…

+

Q&A december

Posted on December 2, 2025 by

Tweet Have a question this is the place for you Source: multiple-sclerosis-research.org

+

NEDA Fudge and Alemtuzumab

Posted on December 1, 2025 by

Tweet No evidence of disease control is typically no relapse no MRI lesions and no progression. Whilst as mentioned I think progtrssion is a composite surrogate of different biologies the question is how good are drugs at inducing NEDA. Here we hear about alemtuzumab and they tell us that the proportion of patients achieving NEDA-3…

+

Know One Know them All?

Posted on December 1, 2025 by

Tweet Are all the anti-CD20 depleting antibodies the same? This study aims to show if rituximab is inferior to ocrelizumab, MSBase said it was. I would ask why? What biology is different?….They are clearly not all the the same in how they do things but they all aim to kill circulating B cells. This study…

+

Kelly Montelo-Murphy – MSAA’s December 2025 Artist of the Month

Posted on December 1, 2025 by

MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Kelly Montelo-Murphy as December’s … Continue reading → Source: blog.mymsaa.org

+

Resistance exercise stands out for easing fatigue in multiple sclerosis

Posted on December 1, 2025 by

Resistance training may be the most effective type of exercise for easing fatigue in people with multiple sclerosis (MS), especially when programs last longer than eight weeks, a meta-analysis found. The study, “Effects of exercise on fatigue and quality of life in multiple sclerosis: a network meta-analysis and systematic review,” was published in the Journal…

+

Know One Know them All?

Posted on November 30, 2025 by

Tweet Are all the anti-CD20 depleting antibodies the same? This study aims to show if rituximab is inferior to ocrelizumab, MSBase said it was. I would ask why? What biology is different?…They are clearly not all the same in how they do things but they all aim to kill circulating B cells. This study is…

+
  • Previous
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 51
  • Next

Recent Posts

  • From our CEO
  • Connection, hope and agency: our Community Day with MS Queensland at the MS Australia Conference
  • Causes, Care and Cures – sharing cutting-edge research at MS Australia’s biennial conference, Brisbane
  • Your Voice Matters: What the 2025 Research and Advocacy Priorities Survey Reveals
  • Anti-Alemtuzumab antibodies

Recent Comments

    Archives

    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • May 2022
    • February 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • July 2019

    Categories

    • Multiple Sclerosis Research
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    NAVBAR

    Archive 1

    MS Search

    Recent

      ©2025 Wicked Sister | Powered by Superb Themes